MichBio members present to legislators at Michigan Biosciences Capitol Day
Tuesday, June 03, 2014
Michigan Biosciences Industry Association (MichBio) members displayed the strength and diversity of the state’s bio-industry today at the second annual Michigan Biosciences Capitol Day
held at the Capitol Building in Lansing, Michigan. Michigan legislators visited with MichBio member companies to learn how the bio-industry contributes to Michigan’s economy, creating jobs today and for the future.
The fully-subscribed lunchtime event featured 12 companies across multiple sectors including medical devices/equipment (BD Accuri Cytometers, Brio Device, DeNovo Sciences, ENT Biotech Solutions, First Sense Medical, and MedBio); biopharmaceuticals (Ash Stevens, Diplomat, and MedImmune); diagnostics and research tools (Cayman Chemical and Neogen); and academic technology transfer (Spartan Innovations). Legislators and staff learned about the wide range of products, discoveries, technologies, and services represented by participating MichBio members.
“Michigan has a rich pedigree in the bio-industry and is home to over 600 bioscience companies, institutions, and organizations, including many global brands. Over 124,000 individuals are employed directly or secondarily in the bio-industry so it’s imperative that legislators and policymakers get a chance to see up-close how the bio-industry impacts Michigan’s economy and health of its citizens,” explained Stephen Rapundalo, PhD, president and CEO of MichBio. “We’re a major economic driver already, and have all the ingredients to be a national and global bioscience leader if we harness growth strategically in public-private partnership.”
Participating companies also met privately with their respective elected representatives to discuss bio-industry policy issues facing them and the state. Similarly, MichBio met with the Biosciences Legislative Caucus to discuss a set of state competitiveness priorities, including:
- Developing a favorable business climate
- Enhancing access to capital for emerging company growth
- Committing to bio-industry development with creative economic development initiatives
- Developing a strategic roadmap essential to grow the bio-industry
- Greater support to higher education for growing innovation and maintaining competitiveness
Rep. Gail Haines (R-Waterford), Rep. Sam Singh (D-East Lansing), Sen. Tonya Schuitmaker (R-Lawton), and Sen. Rebekah Warren (D-Ann Arbor) lead the Biosciences Legislative Caucus (BLC). The BLC is a bipartisan, bicameral body formed in 2007 whose membership is open to any legislator interested in Michigan’s bio-industry. The BLC uses education, communication, and outreach as tools to discuss, promote, and formulate potential policies to help grow the state’s bio-industry. MichBio supports the BLC in part by hosting regular caucus meetings on relevant topics ranging from clinical trials and bio banking, to economic and workforce development.
MichBio thanks its member company MedImmune—the global biologics research and development arm of AstraZeneca—for sponsoring the 2014 Capitol Day event.